Navigation Links
New journal on disruptive science and technology launching in 2012
Date:11/14/2011

ff, Johns Hopkins University; Michael Goldblatt, Functional Genetics; Dean Kamen, DEKA Research; Takeo Kanade, Carnegie Mellon University; Milan Mrksich, Northwestern University; Mark Murcko, Boston, MA; George Poste, Arizona State; Richard Satava, University of Washington Medical Center; Melissa Stark, Accenture; and Peter Thiel, Clarium Capital. View the entire editorial board at http://www.liebertpub.com/dst.

Offering original articles accompanied by video and podcasts from the authors, Disruptive Science and Technology will provide an up-close-and-personal view into extraordinary discoveries presented by developing a direct relationship between reader and author. Readers can become participants in a unique multimedia platform that allows for dialogue among a community of top academic scientists, corporate innovators, business leaders, and futurists who provide unique and fascinating views on the science and technology that will shape our future.

"This year's Nobel prize winner in Chemistry told the world he could not publish his early work in world-class journals because it changed the paradigm of what was accepted," reports Mary Ann Liebert, President of Mary Ann Liebert, Inc., publishers. "Our new journal seeks to be the forum in which exceptional, paradigm-shifting research and development will be published in a world-class journal."


'/>"/>

Contact: Vicki Cohn
vcohn@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News
Source:Eurekalert

Page: 1 2

Related biology news :

1. Winners named for the 2011 AAAS Kavli Science Journalism Awards
2. Journal of the Chinese Chemical Society expands international reach with Wiley-VCH
3. Thomas Jefferson is the first high school to subscribe to the Journal of Visualized Experiments
4. Data publishing in Pensoft journals integrated with the Dryad Data Repository
5. Faculty of 1000 introduces a unique opinion-based journal metric
6. Pumice proposed as home to the first life forms: A new hypothesis in Astrobiology journal
7. Journal focuses on Savannah River National Labratory, Chernobyl Laboratory collaboration
8. Revolutionary changes to the Botanical Code published in 16 journals and 5 languages
9. Human Gene Therapy expands with robust new methods journal
10. Mapping a model: International research on plant species appears in journal Nature
11. News tips from the journal mBio®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2014)... infections and worldwide claims the lives of 160,000 ... University have succeeded in developing a promising vaccination ... , Xavier Saelens (VIB/UGent): "We discovered a new ... development of a novel approach to vaccination against ... small children and elderly people." , RSV: ...
(Date:10/15/2014)... Life, is a non-traditional biophysics textbook and it describes ... a journey of discovery into biological systems and provides ... regulation. It is about how our genes make proteins ... billions of cells in an organism. It quantifies the ... which can be found on both large and small ...
(Date:10/15/2014)... the 44th Rosenstiel Award for Distinguished Work in Biomedical ... the mechanisms of genomic instability and its implications for ... second alumnus to win the Rosenstiel Award; the first, ... Alt is the Charles A. Janeway Professor of Pediatrics ... an investigator at the Howard Hughes Medical Institute at ...
Breaking Biology News(10 mins):New perspectives for development of an RSV vaccine 2New book about life as seen from physics 2Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2
... University paleobiologist Gregory M. Erickson sliced up some ... an international team of scientists identify a new ... only subtle similarities, the FSU researcher determined that ... North America's hulking Tyrannosaurus rex. , Make that ...
... the once almost universally fatal childhood cancer acute lymphoblastic ... future, thanks to improvements in diagnosis and treatment over ... Jude Children's Research Hospital. Almost 4,000 cases of ALL ... two-thirds of which are in children and adolescents, making ...
... and Geoff Garnett (of Imperial College London) suggests that ... controlled through antiretroviral drugs alone, even if universal access ... the open-access international medical journal PLoS Medicine, without additional ... about safe sex, access to drugs is likely to ...
Cached Biology News:FSU biologist says new dinosaur is oldest cousin of Tyrannosaurus rex 2FSU biologist says new dinosaur is oldest cousin of Tyrannosaurus rex 3St. Jude projects 90 percent cure rate for ALL 2St. Jude projects 90 percent cure rate for ALL 3St. Jude projects 90 percent cure rate for ALL 4St. Jude projects 90 percent cure rate for ALL 5Access to antiretrovirals unlikely to reduce HIV infection rates 2
(Date:10/22/2014)... DIEGO and HONG KONG ... innovative rare disease therapeutics enterprise, announced today that rare ... the company as vice president, research. Dr. McKew brings ... including key leadership positions at the National Institutes of ... its acquisition by Wyeth). Dr. McKew will lead aTyr,s efforts ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias Biotherapeutics, ... Company has signed a Notice of Grant Award ... (CIRM), effective October 1, 2014.  The NGA provides ... and the release of additional grant funds pursuant ... award for clinical development of Asterias, product, AST-OPC1. ...
(Date:10/20/2014)... PureTech , a science and technology development ... today the closing of a $55 million growth ... a $120 Billion group of funds. The funding ... forward and to advance new healthcare related products ... really go for the big ideas that can ...
(Date:10/19/2014)... The Latin American hardware encryption display market ... with analysis and forecast of revenue. This market was ... to reach $2,366.8 million by 2018, at a CAGR ... the TOC of the Latin American hardware encryption market ... provided. It also provides a glimpse of the segmentation ...
Breaking Biology Technology:aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 2The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 3
... 22 /PRNewswire-FirstCall/ - Oncothyreon Inc. (Nasdaq: ONTY ... of Darmstadt, Germany, has initiated a global Phase 3 ... with hormone receptor-positive, locally advanced, recurrent or metastatic breast ... developed by Merck KGaA under a license agreement with ...
... , , , , SINGAPORE, June 22 ... The EU,s commitment to achieve a reduction in CO2 emissions by ... of a target of 5.75 percent bio-fuels of all transportation fuel ... States is a smaller market, it is witnessing rapid growth in ...
... BioPharma Corp. (TSX, FSE: HBP) today announced that Dr. ... will be presenting a scientific poster describing L-DOS47 analytical ... Pharmaceutical Scientists ("AAPS") National Biotechnology Conference, which runs from ... and Trade Center in Seattle, Washington. , ...
Cached Biology Technology:Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 2Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 3Oncothyreon announces initiation of Phase 3 trial of Stimuvax in breast cancer 4Government Mandates Create Guaranteed Market for Bio-Fuel, Says Frost & Sullivan 2Government Mandates Create Guaranteed Market for Bio-Fuel, Says Frost & Sullivan 3Government Mandates Create Guaranteed Market for Bio-Fuel, Says Frost & Sullivan 4Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 2Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 3Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 4Helix BioPharma to Present L-DOS47 Analytical Method Development Findings at 2009 AAPS National Biotechnology Conference 5
Sheep polyclonal to ErbB 2 ( Abpromise for all tested applications). Antigen: Recombinant full length c-ErbB2 protein (Human). Entrez GeneID: 2064 Swiss Protein ID: P04626...
200 μg per ml DNA in 10 SSPE, 2 Denhardt's...
Anti-Potassium Channel Kv2.2 Immunogen: Synthetic peptide from rat Kv2.2. Available Date: 38376...
MagSi uniform silica particles coated with a carboxyl group containing polymer, covalently attached to the bead surface....
Biology Products: